Form 4 for MRNA Moderna
Accepted 2022-03-03 00:00:00 ET · period of report 2022-03-01 · accession 0001127602-22-008019 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-03-03 | 2022-03-02 | MRNA | Bancel Stephane | CEO, Dir | G - Gift | — | -154.0K | 5.53M | -3% | — |
| D | 2022-03-03 | 2022-03-02 | MRNA | Bancel Stephane | CEO, Dir | S - Sale | $149.44 | -9,000 | 5.53M | -0.2% | -$1.34M |
| D | 2022-03-03 | 2022-03-01 | MRNA | Bancel Stephane | CEO, Dir | A - Grant | $0.00 | +146.4K | 146.4K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-03-02 | G | D | 4,000 | — | 5,521,535 | D | — | — | (F1) The reported disposition represents a bona fide charitable gift made by the reporting person. |
| 2 | Common | Common Stock | 2022-03-02 | G | D | 150,000 | — | 5,534,535 | D | — | — | (F1) The reported disposition represents a bona fide charitable gift made by the reporting person. |
| 3 | Common | Common Stock | 2022-03-02 | S | D | 9,000 | $149.44 | 5,525,535 | D | — | — | |
| 4 | Derivative | Stock Option (Right to Buy) | 2022-03-01 | A | A | 146,364 | $0.00 | 146,364 | D | $149.52 · 2023-03-01 to 2032-03-01 | 146,364 Common Stock | (F6) 25% of this option will vest and become exercisable on March 1, 2023 with the remainder vesting in twelve (12) equal quarterly installments thereafter. |